2018
DOI: 10.1016/j.jpeds.2018.02.039
|View full text |Cite
|
Sign up to set email alerts
|

Catheter-Related Venous Thrombosis in Hospitalized Pediatric Patients with Inflammatory Bowel Disease: Incidence, Characteristics, and Role of Anticoagulant Thromboprophylaxis with Enoxaparin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 47 publications
1
16
0
Order By: Relevance
“…Thrombosis is a disease involving multiple factors and systems and a major contributor to global health burden [23]. Many approaches, such as changes in the diameter of catheter [24], tuning of catheter-to-vein ratio [25], novel catheter surface coatings [26], use of catheter-locking solutions [27] or anticoagulants [28], and handgrip exercise [29], have been investigated to prevent CRT. Numerous reports on CRT were clinical studies.…”
Section: Discussionmentioning
confidence: 99%
“…Thrombosis is a disease involving multiple factors and systems and a major contributor to global health burden [23]. Many approaches, such as changes in the diameter of catheter [24], tuning of catheter-to-vein ratio [25], novel catheter surface coatings [26], use of catheter-locking solutions [27] or anticoagulants [28], and handgrip exercise [29], have been investigated to prevent CRT. Numerous reports on CRT were clinical studies.…”
Section: Discussionmentioning
confidence: 99%
“…Some studies, carried out in pediatric population, concluded that thromboprophylaxis is safe and well tolerated with a bleeding rate of 1–5% (24, 25). In previous studies (1, 26, 27), patients with venous sinus thrombosis who received heparin did not have more bleeding episodes or worsening, compared with the placebo group, while mortality was also lower in the treatment group (2830). Finally, a systematic review and meta-analysis of the literature, with more than 2,000 pediatric patients included, suggested that thromboprophylaxis in pediatric age is safe and effective (31).…”
Section: Discussionmentioning
confidence: 81%
“…Our results are also strengthened by our use of a nationally representative data set for pediatric hospitalizations, thereby providing more generalizable conclusions than previously published single-center studies. 17,21 An additional novel aspect of our study is the use of a composite outcome of either thrombus or infection associated with PN use. We believe this composite outcome serves as a clinically useful outcome to aid in clinical decision-making.…”
Section: Discussionmentioning
confidence: 99%